HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Simultaneous determination of cyclophosphamide and 4-hydroxycyclophosphamide in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry - application to Chinese systemic lupus erythematosus patients.

AbstractBACKGROUND:
A pharmacogenomics study of cyclophosphamide in systemic lupus erythematosus patients is being conducted in our laboratory in which the plasma concentrations of cyclophosphamide and its active metabolite 4-hydroxycyclophosphamide should be assayed rapidly and sensitively.
METHODS:
A rapid, stable and sensitive liquid chromato-graphy/electrospray ionization tandem mass spectrometry method was developed to simultaneously determine cyclophosphamide and 4-hydroxycyclophosphamide in human plasma with ifosfomide as an internal standard. After a protein precipitation with cold acetonitrile and stabilization of 4-hydroxycyclophosphamide by ansyldrazine and extraction with ethyl acetate, separation was performed on a C18 3.5 μm 2.1 × 50 mm column with mobile phase of acetonitrile and water (50:50, v/v) with 0.1% formic acid at 200 μL/min. The chromatographic run time was 3 min.
RESULTS:
The linear calibration curves ranged from 5 to 5000 ng/mL for cyclophosphamide and 5-500 ng/mL for 4-hydroxycyclophosphamide. The recoveries of the liquid extraction were 54.5%-58.5% for cyclophosphamide and 103.5%-105.5% for 4-hydroxycyclophosphamide. The lower limit of quantification was 5 ng/mL for both analytes. The intra- and inter-day precision was <15% for quality control samples at 4000, 500, 50 ng/mL for cyclophosphamide and 4-hydroxycyclophosphamide at 400, 100, 20 ng/mL. The method was applied in this pharmacogenomics study in Chinese systemic lupus erythematosus patients treated with low-dose cyclophosphamide.
CONCLUSIONS:
The method was efficient with shorter running time and lower limit of quantification compared to previous reports and has been successfully applied in this pharmacogenomics study.
AuthorsWenying Shu, Xueding Wang, Xiuyan Yang, Liuqin Liang, Jiali Li, Zhuojia Chen, Xiao Chen, Jing Jin, Ruiming Li, Lizi Zhao, Min Huang
JournalClinical chemistry and laboratory medicine (Clin Chem Lab Med) Vol. 49 Issue 12 Pg. 2029-37 (Sep 09 2011) ISSN: 1437-4331 [Electronic] Germany
PMID21902573 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Acetates
  • Acetonitriles
  • Immunosuppressive Agents
  • 4-hydroxycyclophosphamide
  • ethyl acetate
  • Cyclophosphamide
  • acetonitrile
Topics
  • Acetates (chemistry)
  • Acetonitriles (chemistry)
  • Asian People
  • Calibration
  • China
  • Chromatography, High Pressure Liquid (standards)
  • Cyclophosphamide (analogs & derivatives, blood, isolation & purification, standards, therapeutic use)
  • Humans
  • Immunosuppressive Agents (blood, standards, therapeutic use)
  • Lupus Erythematosus, Systemic (blood, drug therapy)
  • Solid Phase Extraction
  • Spectrometry, Mass, Electrospray Ionization (standards)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: